Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-11 Sale | 2024-04-15 7:06 pm | Enliven Therapeutics Inc. | ELVN | Patel Anish CHIEF OPERATING OFFICER | 17,500 | $25.03 | $438,099 | 454,744 (Indirect Direct) | View |
| 2024-04-08 Sale | 2024-04-10 8:35 pm | Enliven Therapeutics Inc. | ELVN | Patel Anish CHIEF OPERATING OFFICER | 4,875 | $18.6 | $90,687 | 396,624 (Indirect Direct) | View |
| 2024-03-06 Sale | 2024-03-08 7:52 pm | Enliven Therapeutics Inc. | ELVN | Patel Anish CHIEF OPERATING OFFICER | 4,875 | $15.64 | $76,239 | 401,499 (Indirect Direct) | View |
| 2024-02-06 Sale | 2024-02-08 8:47 pm | Enliven Therapeutics Inc. | ELVN | Patel Anish CHIEF OPERATING OFFICER | 4,875 | $15.11 | $73,658 | 406,374 (Indirect Direct) | View |
| 2024-01-22 Sale | 2024-01-24 6:38 pm | Enliven Therapeutics Inc. | ELVN | Patel Anish Chief Operating Officer | 4,875 | $15.13 | $73,783 | 411,249 (Indirect Direct) | View |
| 2023-12-28 Sale | 2024-01-02 8:00 pm | Enliven Therapeutics Inc. | ELVN | Patel Anish Chief Operating Officer | 13,540 | $15.02 | $203,348 | 416,124 (Indirect Direct) | View |
| 2023-12-22 Sale | 2023-12-27 5:28 pm | Enliven Therapeutics Inc. | ELVN | Patel Anish Chief Operating Officer | 1,085 | $15.03 | $16,306 | 429,664 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-11 Exercise | 2024-04-15 7:06 pm | N/A 2031-03-25 | Enliven Therapeutics Inc. | ELVN | Patel Anish CHIEF OPERATING OFFICER | 14,903 | $0 | 454,744 (Direct) | View |
| 2024-04-11 Exercise | 2024-04-15 7:06 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | Patel Anish CHIEF OPERATING OFFICER | 14,903 | $2.48 | 454,744 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 9:02 pm | N/A 2034-02-12 | Enliven Therapeutics Inc. | ELVN | Patel Anish CHIEF OPERATING OFFICER | 185,000 | $0 | 185,000 (Direct) | View |
| 2023-04-04 Option Award | 2023-04-06 8:34 pm | N/A 2033-04-04 | Enliven Therapeutics Inc. | ELVN | Patel Anish Chief Operating Officer | 206,000 | $0 | 206,000 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-27 9:35 pm | N/A 2030-06-15 | Enliven Therapeutics Inc. | ELVN | Patel Anish Chief Operating Officer | 519,963 | $0 | 519,963 (Direct) | View |